Publication of Final Terms - Issue of Senior Notes

RNS Number : 8378J
Aviva PLC
14 September 2016
 

 

14 September 2016

 

Publication of Final Terms pursuant to the issue of €350m 0.100 per cent. Senior Notes due 13 December 2018 by Aviva plc (the "Company")

 

The following Final Terms have been filed with the United Kingdom Listing Authority (the "UKLA") and are available for viewing:

 

Final Terms dated 12 September 2016 (the "Final Terms") relating to the issue by the Company of €350m 0.100 per cent. Senior Notes due 13 December 2018 under the £7,000,000,000 Euro Note Programme (the "Programme") of the Company dated 22 April 2016 (as supplemented on 30 August 2016). The Programme enables the Company to issue debt instruments, including a range of subordinated securities.

The Final Terms should be read in conjunction with the Base Prospectus dated 22 April 2016, as supplemented by a Supplemental Prospectus dated 30 August 2016 (together the 'Prospectus').

 

To view the Final Terms, please paste the following URL from the following list into the address bar of your browser:

 

http://www.rns-pdf.londonstockexchange.com/rns/8378J_-2016-9-14.pdf 

 

Copies of the following documents are also available from the websites listed below:

 

Prospectus approved by the UKLA on 22 April 2016 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/8378J_1-2016-9-14.pdf

 

Supplemental Prospectus approved by the UKLA on 30 August 2016 relating to the Programme

http://www.rns-pdf.londonstockexchange.com/rns/8378J_2-2016-9-14.pdf

 

 

Company's Annual Report and Accounts for the year ended 31 December 2014

http://www.aviva.com/investor-relations/reports/

 

Company's Annual Report and Accounts for the year ended 31 December 2015

http://www.aviva.com/investor-relations/reports/

 

The Prospectus and the documents incorporated by reference therein have been submitted to the National Storage Mechanism and are available for inspection at  http://www.Hemscott.com/nsm.do.

 

This announcement does not constitute or form part of an offer to sell or the solicitation of an offer to subscribe for or otherwise acquire any securities.  The securities referred to herein have not been and will not be registered under the U.S. Securities Act of 1933 or with any securities regulatory authority of any other State or other jurisdiction of the United States.  Accordingly, these securities may not be offered, sold or delivered in the United States or to, or for the account or benefit of, U.S. persons (as defined in the U.S. Internal Revenue Code of 1986, as amended, and regulations thereunder).

 

Please note that the information contained in the Prospectus may be addressed to and/or targeted at persons who are residents of particular countries (specified in the Prospectus) only and is not intended for use and should not be relied upon by any person outside these countries. Prior to relying on the information contained in the Prospectus, you must ascertain from the Prospectus whether or not you are part of the intended addressees of the information contained therein.

 

Your right to access this service is conditional upon complying with the above requirements.

 

END

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
PFTEAFNLFFLKEFF

Companies

Aviva (AV.)
UK 100

Latest directors dealings